Viela Bio

About:

Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases.

Website: https://vielabio.com/

Twitter/X: VielaBio

Top Investors: Temasek Holdings, Goldman Sachs, AstraZeneca, Hillhouse Investment, Cormorant Asset Management

Description:

Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases. The Company’s portfolio selectively targets shared critical pathways that are the root cause of disease. Led by a team of global leaders in inflammation and autoimmunity, Viela Bio strives to be a fully integrated biotechnology company, helping millions of patients worldwide. Viela Bio is located in Gaithersburg, Maryland.

Total Funding Amount:

$526M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Gaithersburg, Maryland, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)vielabio.com

Founders:

Number of Employees:

101-250

Last Funding Date:

2020-05-27

IPO Status:

Delisted

© 2025 bioDAO.ai